Molecular Characteristics and Antimicrobial Resistance of Carbapenem-Resistant Klebsiella pneumoniae Isolated at Can Tho University of

Molecular Characteristics and Antimicrobial Resistance of Carbapenemase-Producing Klebsiella pneumoniae Isolated at Can Tho University of Medicine and Pharmacy Hospital, 2024–2025

The mCIM → D73C → simplex PCR workflow demonstrated practical value for carbapenemase detection in clinical microbiology laboratories and described antimicrobial susceptibility profiles and analyze associations between resistance genotype and phenotype.

Molecular Characterization and Resistance Gene Co-occurrence in Carbapenem-Resistant Klebsiella peumoniae from a Bangkok Tertiary Hospital, Thailand.

INTRODUCTION Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a significant global health concern due to its high morbidity and mortality rates and limited treatment options. We investigated the molecular characteristics and co-occurrence of resistance genes in CRKP isolates from a tertiary hospital in Bangkok, Tha...

Molecular characterization of carbapenem resistance and hypervirulence determinants of Klebsiella pneumoniae circulating in a tertiary hospital in Cyprus

blaOXA-23/blaNDM co-carriage among clinical Acinetobacter baumannii isolates from southern Vietnam and its association with multiclass antimicrobial resistance.

Background Carbapenem-resistant Acinetobacter baumannii (CRAB) is a World Health Organization critical-priority pathogen, but the contribution of blaOXA-23 and blaNDM co-carriage to resistance across antimicrobial classes is poorly defined in southern Vietnam. Objectives To describe the carbapenemase gene profile and...

Genomic Epidemiology of Carbapenem-Resistant Enterobacterales in a Bulgarian University Hospital (2022–2025): Emergence and Persistence of Klebsiella pneumoniae ST6260 Carrying blaNDM-5

The genomic epidemiology and genomic characteristics of clinically significant CRE recovered at University Hospital “Lozenetz”, Sofia, between 2022 and 2025 indicate that ST6260 is an emerging hospital-associated multidrug-resistant lineage.

Extensively Drug-Resistant ST16 Klebsiella pneumoniae Co-Harboring blaKPC-2, blaOXA-181, and Chromosomal blaNDM-4: Genomic Features and Therapeutic Challenges

Purpose Carbapenem-resistant Klebsiella pneumoniae (CRKP) represents a major global public health threat due to its high-level antimicrobial resistance and limited therapeutic options. The emergence of CRKP isolates co-harboring multiple carbapenemase genes further complicates clinical management and infection control....